Details of the Drug-Related molecule(s) Interaction Atlas

CS-W011402 Drug Info

DICHLOROBIS[DI-TERT-BUTYL(4-DIMETHYLAMINOPHENYL)PHOSPHINO]PALLADIUM(II); bis(di-tert-butyl(4-dimethylaminophenyl)-phosphine)dichloropalladium(II); DICHLOROBIS[DI-TERT-BUTYL(4-DIMETHYLAMINOPHENYL)PHOSPHINE]PALLADIUM(II); SCHEMBL113074; US9598421, Example 8; KS-00000ESS; AWOFSUFKCXRJMV-UHFFFAOYSA-N; XRZMZNIQMNUFBE-UHFFFAOYSA-L; AJBUBMMXJAOMTF-UHFFFAOYSA-N; BDBM302439; CS-W011402; bis(di-tert-butyl(4-dimethylaminophenyl)phosphino)dichloropalladium; dichloro(bis{di-tert-butyl[4-(dimethylamino)phenyl]phosphoranyl})palladium

Cross-matching ID

PubChem CID

58567970

TTD Drug ID

DM5BFJO

General Information of Drug (ID: DM5BFJO)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Phosphodiesterase 4C (PDE4C)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ZINC584606052	DMYCH0G	N. A.	N. A.	Patented	[1]
US10077269, Example 6	DMOZ84C	N. A.	N. A.	Patented	[1]
RS-25344	DM0W2IS	Discovery agent	N.A.	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Imidazopyridazine compounds. US9598421.
2	Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors. Cell Signal. 1998 Jun;10(6):427-40.